| | | | ImClone Rejects Bristol-Myers Offer
| | September 10, 2008 | Biotechnology company ImClone Systems (New York, NY) has rejected the offer it received last month from its cancer drug partner Bristol-Myers (BMS, New York, NY) to acquire ImClone for $60 per share. |
| |
|